New Key Statistics Module, Z-Score and F-Score
NEOE:ABBV Key Ratios
Market Cap C$ M | 453,191.78 |
Enterprise Value C$ M | 544,958.40 |
P/E(ttm) | 62.77 |
PE Ratio without NRI | 16.81 |
Forward PE Ratio | 14.32 |
Price/Book | 52.94 |
Price/Sales | 5.77 |
Price/Free Cash Flow | 20.52 |
Price/Owner Earnings | 36.04 |
Payout Ratio % | 0.57 |
Revenue (TTM) C$ M | 75,256.00 |
EPS (TTM) C$ | 0.41 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | 14.70 |
5-y EBITDA Growth Rate % | 15.50 |
y-y EBITDA Growth Rate % | -4.00 |
EV-to-EBIT | 38.42 |
EV-to-EBITDA | 20.80 |
PEG | 1.08 |
Shares Outstanding M | 16,697.55 |
Net Margin (%) | 9.22 |
Operating Margin % | 26.13 |
Pre-tax Margin (%) | 12.96 |
Quick Ratio | 0.54 |
Current Ratio | 0.65 |
ROA % (ttm) | 3.63 |
ROE % (ttm) | 59.19 |
ROIC % (ttm) | 8.83 |
Dividend Yield % | 3.50 |
Altman Z-Score | 1.83 |
NEOE:ABBV Number of Guru Trades
NEOE:ABBV Volume of Guru Trades
Gurus Latest Trades with NEOE:ABBV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NEOE:ABBV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AbbVie Inc Insider Transactions
No Available Data